DE69816304D1 - Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren - Google Patents

Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren

Info

Publication number
DE69816304D1
DE69816304D1 DE69816304T DE69816304T DE69816304D1 DE 69816304 D1 DE69816304 D1 DE 69816304D1 DE 69816304 T DE69816304 T DE 69816304T DE 69816304 T DE69816304 T DE 69816304T DE 69816304 D1 DE69816304 D1 DE 69816304D1
Authority
DE
Germany
Prior art keywords
rifamycine
animals
derivative
treating mastitis
mastitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816304T
Other languages
English (en)
Inventor
Kenji Fujii
Katsuji Yamashita
Kazunori Hosoe
J Yancey
L Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of DE69816304D1 publication Critical patent/DE69816304D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69816304T 1997-07-29 1998-07-29 Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren Expired - Lifetime DE69816304D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90196497A 1997-07-29 1997-07-29
PCT/US1998/015308 WO1999006047A1 (en) 1997-07-29 1998-07-29 Use of rifamycin derivative for treating mastitis in a domestic animal

Publications (1)

Publication Number Publication Date
DE69816304D1 true DE69816304D1 (de) 2003-08-14

Family

ID=25415132

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816304T Expired - Lifetime DE69816304D1 (de) 1997-07-29 1998-07-29 Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren

Country Status (9)

Country Link
EP (1) EP1001778B1 (de)
JP (1) JP2001511451A (de)
KR (1) KR20010022033A (de)
CN (1) CN1265594A (de)
AU (1) AU756367B2 (de)
CA (1) CA2297012A1 (de)
DE (1) DE69816304D1 (de)
NZ (1) NZ503027A (de)
WO (1) WO1999006047A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007503439A (ja) * 2003-08-22 2007-02-22 アクティブバイオティクス インコーポレイティッド リファマイシンアナログおよびそれらの使用法
CA2538078C (en) 2003-09-25 2012-12-04 Activbiotics, Inc. Rifalazil formulations
NZ702087A (en) * 2012-06-29 2016-12-23 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
CA2886264A1 (en) * 2012-09-12 2014-03-20 Salix Pharmaceuticals, Inc. Methods of administering rifaximin without producing antibiotic resistance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2248024A1 (en) * 1973-10-17 1975-05-16 Aries Robert Treatment of bovine mastitis using rifamycins - and pref. antibiotics active against gram negative bacteria
JPS63183587A (ja) * 1985-02-05 1988-07-28 Kanegafuchi Chem Ind Co Ltd ベンゾキサジノリフアマイシン誘導体
CA1304363C (en) * 1988-11-01 1992-06-30 Takehiko Yamane 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same

Also Published As

Publication number Publication date
CA2297012A1 (en) 1999-02-11
NZ503027A (en) 2002-10-25
AU756367B2 (en) 2003-01-09
EP1001778A1 (de) 2000-05-24
EP1001778B1 (de) 2003-07-09
WO1999006047A1 (en) 1999-02-11
AU8584498A (en) 1999-02-22
CN1265594A (zh) 2000-09-06
KR20010022033A (ko) 2001-03-15
JP2001511451A (ja) 2001-08-14

Similar Documents

Publication Publication Date Title
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69612649D1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69609868T2 (de) Neue steroidester zur behandlung von hauterkrankungen
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69801089D1 (de) Verfahren und Vorrichtung zum tierfreundlichen Töten von Fischen
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
ATE257189T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
ATE297124T1 (de) Verfahren und vorrichtung zur behandlung von frischfleisch
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE69721756D1 (de) Paroxetine zur behandlung von depression
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69521696T2 (de) Verfahren zum melken von tieren
DE69816304D1 (de) Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren
DE69905551D1 (de) Verfahren und vorrichtung zum abtöten von wassertieren
ATE307871T1 (de) Verfahren zur behandlung von gewebe
DE69602445D1 (de) Anlage zur trocknung von tierexkrementen insbesondere von geflügelnexkrement
DE69812599D1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69601199T2 (de) Verfahren zum Melken von Tieren
DE69701726D1 (de) Verfahren zur behandlung von knitterempfindlichen geweben
DE69527859T2 (de) Verfahren zum Melken von Tieren
DE69533397D1 (de) Verfahren zur behandlung von hypertonie
DE69836018D1 (de) Verfahren zur behandlung eines gegenstandes
DE59503186D1 (de) Vorrichtung zur spülung von melkanlagen
DE29615811U1 (de) Vorrichtung zur Behandlung von Großtieren

Legal Events

Date Code Title Description
8332 No legal effect for de